129 related articles for article (PubMed ID: 24281866)
1. MMP-2, -9 and TIMP-1, -2 assays in keratinocyte cultures.
Kobayashi T
Methods Mol Biol; 2014; 1195():145-55. PubMed ID: 24281866
[TBL] [Abstract][Full Text] [Related]
2. MMP-9 and TIMP-1 assays in keratinocyte cultures.
Kobayashi T
Methods Mol Biol; 2005; 289():201-8. PubMed ID: 15502185
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of the secretions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 from human keratinocytes in culture.
Kobayashi T; Hattori S; Nagai Y; Tajima S
IUBMB Life; 2000 Sep; 50(3):221-6. PubMed ID: 11142351
[TBL] [Abstract][Full Text] [Related]
4. An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
You J; Madigan MC; Rowe A; Sajinovic M; Russell PJ; Jackson P
Urol Oncol; 2012; 30(4):502-8. PubMed ID: 20864363
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes.
Lan CC; Liu IH; Fang AH; Wen CH; Wu CS
Br J Dermatol; 2008 Nov; 159(5):1103-15. PubMed ID: 18717678
[TBL] [Abstract][Full Text] [Related]
6. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
7. Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and -9 and their inhibitors.
Sawicki G; Marcoux Y; Sarkhosh K; Tredget EE; Ghahary A
Mol Cell Biochem; 2005 Jan; 269(1-2):209-16. PubMed ID: 15786734
[TBL] [Abstract][Full Text] [Related]
8. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
9. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ
J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
Furuya M; Ishikura H; Kawarada Y; Ogawa Y; Sakuragi N; Fujimoto S; Yoshiki T
Gynecol Oncol; 2000 Aug; 78(2):106-12. PubMed ID: 10926788
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
12. Imbalance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 is associated with pulmonary emphysema in Klotho mice.
Funada Y; Nishimura Y; Yokoyama M
Kobe J Med Sci; 2004; 50(3-4):59-67. PubMed ID: 15864012
[TBL] [Abstract][Full Text] [Related]
13. Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood.
Mannello F; Jung K; Tonti GA; Canestrari F
Clin Biochem; 2008 Dec; 41(18):1466-73. PubMed ID: 18926810
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
[TBL] [Abstract][Full Text] [Related]
15. Infection with human cytomegalovirus alters the MMP-9/TIMP-1 balance in human macrophages.
Strååt K; de Klark R; Gredmark-Russ S; Eriksson P; Söderberg-Nauclér C
J Virol; 2009 Jan; 83(2):830-5. PubMed ID: 18945772
[TBL] [Abstract][Full Text] [Related]
16. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models].
Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602
[TBL] [Abstract][Full Text] [Related]
17. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.
Chen YS; Langhammer T; Westhofen M; Lorenzen J
Allergy; 2007 Jan; 62(1):66-72. PubMed ID: 17156344
[TBL] [Abstract][Full Text] [Related]
18. Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1,-8, and -13 and of TIMP-1.
Bachmeier BE; Nerlich AG; Boukamp P; Lichtinghagen R; Tschesche H; Fritz H; Fink E
Biol Chem; 2000; 381(5-6):509-16. PubMed ID: 10937883
[TBL] [Abstract][Full Text] [Related]
19. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
[TBL] [Abstract][Full Text] [Related]
20. Complexes of gelatinases and tissue inhibitor of metalloproteinases in human seminal plasma.
Shimokawa K; Katayama M; Matsuda Y; Takahashi H; Hara I; Sato H
J Androl; 2003; 24(1):73-7. PubMed ID: 12514086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
